Ethics in the digital workplace
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
DSM is to restructure its money-losing anti-infectives business, closing capacity in Europe and increasing output in Asia. 400 jobs or 13% of the business's total will go. Weak markets, the decline of the dollar, and strong growth in Asia are cited as main reasons for the restructuring. A plant at Delft and a plant at Geleen, the Netherlands, will close in 2005. A joint venture with Glaxo SmithKline at Irvine, UK is to end in 2005. DSM is to expand and upgrade production at its anti-infectives plant at Toansa, India, and at its joint venture's at Harbin, Zhang Jiakou, and Zibo, China. Antibiotics markets in China and India continue to grow. About 250 of the job cuts will be in the Netherlands. The restructuring should mean annualized cost savings of tens of millions of euros within two years.
Eurofound (2004), DSM Anti-Infectives, Internal restructuring in World, factsheet number 60968, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60968.